Rivia
Unified Intelligence Layer for Clinical Trials
Zurich, Switzerland · $18.5M raised
- Total Funding
- $18.5M
- Last Round
- $15.0M Series AMar 2026
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
AI-powered data analytics platform unifying clinical trial data for biopharma companies.
Summary
Rivia is a Biotech company based in Zurich, Switzerland. It has raised $18.5M in total across 2 rounds, most recently a $15.0M Series A round in Mar 2026. Investors include Speedinvest, Earlybird Venture Capital and Nina Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2026
Sign up to see all 2 events
Funding: Seed through Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Neuralink develops investigational implantable brain-computer interfaces that help people with pa...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rivia"><img src="https://indexed.vc/api/badge/company/rivia" alt="Rivia on Indexed.vc" width="260" height="76" /></a>